Insider · CIK 0001787242
Riebe Michael T
Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA
Transactions
9
Companies
1
Filings
4
CIK
0001787242
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-06-08 | Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2022-06-03 | Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-12-03 | Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-06-12 | Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Riebe Michael T0000899243-23-014894SEC(opens sec.gov)
- 4Riebe Michael T0001567619-22-012467SEC(opens sec.gov)
- 4Riebe Michael T0001567619-20-020723SEC(opens sec.gov)
- 4Riebe Michael T0001567619-20-012252SEC(opens sec.gov)
Companies
Address
C/O SATSUMA PHARMACEUTICALS, INC. 400 OYSTER POINT BOULEVARD, SUITE 221
SOUTH SAN FRANCISCO, CA, 94080